Chapter 11. Future Antithrombotic Therapy
- 1 January 1992
- book chapter
- Published by Elsevier
Abstract
No abstract availableThis publication has 57 references indexed in Scilit:
- The Pathogenesis of Coronary Artery Disease and the Acute Coronary SyndromesNew England Journal of Medicine, 1992
- The Pathogenesis of Coronary Artery Disease and the Acute Coronary SyndromesNew England Journal of Medicine, 1992
- Structure‐function relationships of hirulog peptide interactions with thrombinFEBS Letters, 1991
- Geometry of binding of the Nα‐tosylated piperidides of m‐amidino‐, p‐amidino‐ and p‐guanidino phenylalanine to thrombin and trypsinFEBS Letters, 1991
- A new class of potent thrombin inhibitors that incorporates a scissile pseudopeptide bondFEBS Letters, 1991
- Geometry of binding of the benzamidine‐ and arginine‐based inhibitors Nα‐(2‐naphthyl‐sulphonyl‐glycyl)‐dl‐p‐amidinophenylalanyl‐piperidine (NAPAP) and (2R,4R)‐4‐methyl‐1‐[Nα‐(3‐methyl‐1,2,3,4‐tetrahydro‐8‐quinolinesulphonyl)‐l‐arginyl]‐2‐piperidine carboxylic acid (MQPA) to human α‐thrombinEuropean Journal of Biochemistry, 1990
- TiclopidineDrugs, 1990
- Reaction of thrombin and proteinases of the fibrinolytic system with a mechanism-based inhibitor, 3,4-dihydro-3-benzyl-6-chloromethylcoumarinBiochimica et Biophysica Acta (BBA) - Protein Structure and Molecular Enzymology, 1990
- Biochemistry and Genetic Engineering of HirudinSeminars in Thrombosis and Hemostasis, 1989
- High-resolution NMR studies of fibrinogen-like peptides in solution: resonance assignments and conformational analysis of residues 1-23 of the A.alpha. chain of human fibrinogenBiochemistry, 1988